Healhcare Analyst Stavropoulos discusses emerging targets with differentiated strategies in Alzheimer’s Disease with CEOO’Connell of Acumen Pharmaceuticals, CMO Moebius of Athira Pharma, CMO Palumbo of Biovie Pharmaceuticals, CEO Ricciardi of Cognition Therapetics on an Analyst/Industry conference call to be held on June 23 at 10:30 am. (Webcast Link):(https://cantor.zoom.us/webinar/register/WN_JCBSSsa6RrC-cwxlS6MZ_Q#/registration)
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABOS:
- Cantor Fitzgerald healthcare analyst holds an analyst/industry conference call
- Acumen to present topline results from Phase 1 study of ACU193
- Acumen Pharmaceuticals to Present Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease During Featured Research Session at the Alzheimer’s Association International Conference (AAIC®) 2023
- Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
- Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference